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 Introduction
Salmonellosis is one of the many diarrheal diseases
fecting pre-weaned dairy calves. Salmonella organisms
e commonly isolated from dairy farms (Fossler et al.,
2004) and the fecal-oral transmission route can occur from
dam to offspring. Calves can also acquire the organism
from fecal-contaminated fomites or the environment.
Calves manifest the disease as diarrhea, fever, anorexia,
and dehydration all of which signiﬁcantly compromise the
development and maturation of the animal. Further costs
include treatment with electrolytes or antibiotics or both,
and some calves still perish because of the increasing
prevalence of antibiotic resistance in Salmonella (Cum-
mings et al., 2013) and hypervirulence associated with
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A B S T R A C T
Salmonellosis is an insidious and potentially epidemic problem in pre-weaned dairy
calves. Managing this disease, or any other diarrheal disease, is a ﬁnancial burden to
producers. Calf mortalities and medicinal treatments are overt costs of salmonellosis,
while hidden costs include hampered weight gains and persistent intestinal colonization
of the pathogen. In this study, we examined the anti-Salmonella effects of Saccharomyces
cerevisiae fermentation products (SCFP) incorporated into both the milk replacer and the
starter grain. In a blinded study, 2–8 day-old calves were fed SCFP (n = 20 calves) or an
SCFP-free Control (n = 20 calves) for two weeks before and three weeks after experimental
challenge with Salmonella enterica serotype Typhimurium. Following the challenge, calves
were monitored for clinical signs and parameters associated with salmonellosis. Calves
were then euthanized and examined for rumen development and intestinal Salmonella
colonization. When compared to calves that received milk replacer and feed lacking SCFP,
calves fed SCFP had fewer bouts of diarrhea and fever. Rumens from these calves were
more developed, as measured by the length of papillae, which is consistent with the
enhanced weight gain observed in this treatment group. Additionally, Salmonella intestinal
colonization was reduced in SCFP-fed calves and Salmonella fecal shedding disappeared at
an earlier stage in these calves. This study revealed that the combination of two
proprietary S. cerevisiae fermentation products provide marked beneﬁt for preventing the
negative effects of salmonellosis in pre-weaned dairy calves, while also boosting
productivity. The mechanism of action needs to be clariﬁed, but it may be related to the
observed decrease in colonization by the pathogen and increase in rumen development.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
 Corresponding author at: 2028 VetMed, Ames, IA 50011,
ited States. Tel.: +1 515 294 0912; fax: +1 515 294 2315.
E-mail address: stevec@iastate.edu (S.A. Carlson).
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Veterinary Microbiology
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ore, calves that survive salmonellosis can be long-term
arriers of the pathogen (Nielsen et al., 2012) and these
dult animals can serve as a persistent source for new
fections in the herd (Cobbold et al., 2006). Environmental
ersistence also contributes to this problem (Cobbold et al.,
006).
Preventing Salmonella infections currently focuses on a
accine technology (Hermesch et al., 2008). Unfortunately,
is vaccine is only for cattle that are six months or older
us pre-weaned calves are dependent upon colostral
assive immunization from the vaccinated dam. Anti-
almonella bacterins have been tried but are frequently
nsuccessful because of the immunodominance of the
almonella O-antigen (Barat et al., 2012) and serovar
peciﬁcity (House et al., 2001). Anti-lipopolysaccharide
ntiserum and lipopolysaccharide toxoids are available but
e anti-Salmonella beneﬁts have not been clearly estab-
shed. Thus Salmonella prophylaxis is not optimal at this
me in the pre-weaned calf (Lanzas et al., 2008), although
accinating the dam will reduce the environmental
xposure of the calf.
It has been shown that soluble components present in
accharomyces cerevisiae fermentation products (SCFP)
nhance gut health (Jensen et al., 2008a) and promote
mune function (Jensen et al., 2007). When supplemen-
d to the starter grain, SCFP improved rumen develop-
ent, starter grain intake, and BW gain of non-challenged
alves (Lesmeister et al., 2004). Additionally, SCFP was
hown to improve the gastrointestinal health of calves in a
almonella endemic herd (Magalha˜es et al., 2008). Because
f these beneﬁts associated with SCFP, we examined its
nti-Salmonella effects when fed to pre-weaned dairy
alves experimentally infected with Salmonella. The
peciﬁc aims of this study were to determine the effects
f the combination of two proprietary SCFP (Diamond V
martCareTM and Diamond V Original XPCTM) on the
rowth and rumen development, clinical signs of salmo-
ellosis, Salmonella shedding, and intestinal colonization of
almonella in pre-weaned dairy calves experimentally
fected with Salmonella.
. Materials and methods
.1. Calves and pre-infection treatments
Animal experiments were approved by the Animal
are and Use Committee at Iowa State University. Forty
olstein or Holstein-cross calves (32 females and 8
ales) were purchased from a local supplier in northwest
wa. Calves were fed colostrum for the ﬁrst two days
fter birth and then fed a standard milk replacer until
hipment to Iowa State University at 2–8 days of age.
pon arrival at an animal biosafety level-2 building at
wa State University, calves were weighed (28–47 kg,
ith Holstein–Jersey crosses representing the lower
eights) and randomly assigned (without redistribution)
o one of two separate but adjacent rooms. Each room
ad constant ambient temperatures (about 22 8C) and
umidity (about 40%) and was ventilated by negative
ressure through HEPA ﬁlters. Calves were housed in
individual 18 m2 pens on Tenderfoot-type ﬂooring
without bedding.
Two separate experiments were performed each using
20 calves (10 per group) of similar ages (2–4 days in one
experiment and 6–8 days in the other experiment), and
treatment groups were alternated in the two different
rooms in each experiment in order to avoid a ‘‘room effect’’.
Each room was fed either SCFP or the Control to avoid the
potential for inappropriate administration of a treatment
within a room. Rooms were alternated between the two
experiments, i.e., in the ﬁrst experiment calves in ‘‘Room
A’’ received SCFP while calves in this same room received
the Control in the second experiment.
Calves were randomly assigned to one of two treat-
ments: Control (no additive in milk replacer or starter
grain) or diet that contained two proprietary S. cerevisiae
fermentation products delivered separately (SCFP; 1 g/
head/d SmartCareTM [0.15% inclusion rate in conventional
milk replacer] and 3.5 g/head/d Original XPCTM adminis-
tered orally via gelatin capsule; Diamond V, Cedar Rapids,
Iowa). SmartCare is a water dispersible product that can be
added directly to milk or milk replacer as a supplement for
pre-weaning liquid calf diets (starting at d 1). Original XPC
is dry feed product commonly used in pre-weaning calf
starter diets. The combination of these products is the basis
for Diamond V’s dairy calf program during the pre-
weaning phase. A gelatin capsule containing 3.5 g/head/
d grain matrix used to produce XPC was given to Control
calves to equalize the nutrients, although minimal,
contributed by XPC.
All calves were fed a non-medicated milk replacer (20%
all-milk protein, 20% fat; Land O’Lakes Animal Milk
Products, Shoreview, MN) at a volume equivalent rate of
approximately 10% of arrival BW twice per day (i.e., 5% of
BW each feeding) for the duration of the trial. Milk replacer
was mixed in single batches using warm water and a
cordless drill-driven stirrer. Speciﬁcally, each calf received
6 oz of milk replacer in 1 qt water bid, in which the milk
replacer was 18.8% (w/v) of the solution.
Calves were fed calf starter (Calf StartenaTM, 18% crude
protein, 0.005% decoquinate, Purina Mills, LLC, St. Louis,
MO) and water ad libitum, although it was not feasible to
measure intake of either because of spillage and other
uncontrollable factors. The Iowa State University investi-
gators (M.T.B., K.L.A., and S.A.C.) were blinded as to which
calves received the Control or SCFP treatments. Speciﬁcal-
ly, the Diamond V investigators (I.Y. and M.F.S.) notiﬁed a
third party (scientists at the Ofﬁce of Intellectual Property
at Iowa State University) as to the identity of the treatment
groups prior to the onset of the studies. Once the studies
were completed, the Iowa State University investigators
revealed the data to the Ofﬁce of Intellectual Property who
then revealed the identity of the treatment groups.
In the two-week pre-infection phase, six to seven calves
from each group were orally treated with one dose of
sulfamethazine (356 mg/kg; SustainTM, Bimeda, Oakbrook
Terrace, IL) for veterinarian diagnosed coccidial infections
manifested by blood in the feces. This treatment alleviated
the bloody feces within 3 d of treatment. Treatment with
sulfamethazine was deemed to not have a negative effect
on the outcome of the trial since the Salmonella strain used
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M.T. Brewer et al. / Veterinary Microbiology 172 (2014) 248–255250 this study is resistant to sulfonamides and equivalent
mbers of calves from each experimental group were
bjected to sulfamethazine treatment.
. Salmonella infection of calves
Calves were conﬁrmed to be Salmonella-free by fecal
lture on arrival and on d 7 and 12 post-arrival.
eciﬁcally, 1 g of freshly voided feces was diluted in
 mL of Lennox L broth (Invitrogen, Carlsbad, CA). After
ttling, an aliquot (100 mL) of this mixture was streaked
to and then incubated overnight at 37 8C on XLD agar
isher Scientiﬁc, Pittsburgh, PA) selective for Salmonella
at appear as red colonies with black centers. All pre-
fection fecal samples were free of Salmonella. Sulfa-
ethazine was not used in the XLD agar for pre-infection
sessment. SL1344 was plated on XLD as a positive control
ring the experiments.
At d 14 post-arrival (d 0 post-infection), calves were
ally inoculated with Salmonella enterica serotype Typhi-
urium strain SL1344 (Wray and Sojka, 1978; personal
llection of S.A.C.) at the dose of 2  106 CFU/kg BW
iong et al., 2013). The Salmonella inoculum was prepared
d dosed as described previously by the Carlson
oratory (Xiong et al., 2013). The inoculum was placed
 the gelatin capsule containing the Control or SCFP,
hich was administered using a small balling gun. Our
pirical studies revealed that the strain SL1344 was
able after incubation with either the Original XPCTM or
e Control treatment. That is, pre-inoculated experiments
vealed that SL1344 was 100% viable and recoverable
ter remaining in the Control- or SCFP-containing gelatin
psule for 24 h. Additionally, the virulence of SL1344 was
tained (as determined by a tissue culture invasion assay)
llowing recovery from the Control- or SCFP-containing
psule (data not shown).
. Assessment of clinical parameters in calves
Pyrexia and diarrhea are frequently observed compo-
nts of salmonellosis in calves (Smith et al., 1979). On d 0, 1,
3, 4, 5, 6, 7, 10, and 21 post-infection, rectal temperatures
ere measured and diarrhea was assessed on an ordinal
ale. Diarrhea scoring was as follows: 0, no diarrhea; 1, mild
arrhea; 2, profuse diarrhea; or 3, profuse diarrhea with
ood. This determination was performed by one investiga-
r (S.A.C.), who was blinded to the treatment groups, with
st experience with experimental salmonellosis.
. Assessment of Salmonella shedding in calves
Fecal shedding of Salmonella is a highly variable and
oradic occurrence in calves infected with Salmonella
irchner et al., 2012). Nonetheless, this event is of
portance for the spread of this pathogen (Lanzas
 al., 2010). On d 0, 1, 2, 3, 4, 5, 6, 7, 10, and 21 post-
fection, 1 g of freshly voided feces was brieﬂy vortexed in
 mL of Lennox L broth (Invitrogen, Carlsbad, CA). An
quot of this mixture (100 mL) was incubated overnight
 37 8C on XLD agar containing the Committee
 Laboratory Standards Institute-derived (CLSI, 2008)
breakpoint concentration (512 mg/mL) of sulfamethazine
(Sigma–Aldrich, St. Louis, MO), i.e., a concentration that
will enable the growth of SL1344 but will inhibit the
growth of many other enteric bacteria. The following day
red colonies with black centers were enumerated and CFU/
g of feces was calculated based on a dilution factor equal to
200.
2.5. Assessment of intestinal colonization by Salmonella
Intestinal colonization by Salmonella contributes to the
persistence of the pathogen (Cobbold et al., 2006) and the
fecal shedding that transmits the microbe to other cattle.
On d 21 post-infection, all calves were euthanized using
xylazine (0.5 mg/kg, intramuscular, Lloyd Laboratories,
Walnut, CA) and pentobarbital (100 mg/kg, intravenous,
Fort Dodge Laboratories, Fort Dodge, IA). A 2 cm section
(approximately 1 g) of distal ileum was aseptically
removed from each calf and cut longitudinally. Each
section was placed in 20 mL Lennox L broth (Invitrogen,
Carlsbad, CA) and brieﬂy vortexed to dislodge the
Salmonella. An aliquot (100 mL) of this mixture was then
dispersed onto XLD agar containing sulfamethazine (to
prevent the growth of other bacteria) that were incubated
overnight at 37 8C. The following day red colonies with
black centers were enumerated and CFU/g of ileum was
calculated based on a dilution factor equal to 200.
2.6. Assessment of rumen development in calves
Salmonella, and any other enteric pathogen, can have a
negative impact upon performance in the pre-weaned calf.
It was hypothesized that SCFP may abrogate salmonellosis
by promoting overall gastrointestinal health and improv-
ing rumen development in pre-weaned calves. Therefore,
both weight gain and the size of rumen papillae were
assessed in Salmonella-infected calves fed SCFP. Following
euthanasia, a 4 cm2 section of a ventrolateral portion of the
rumen was removed and placed in 10% buffered-neutral
formalin. Rumen tissues were submitted to the Histopa-
thology Laboratory at the College of Veterinary Medicine at
Iowa State University. Tissues were prepared using
standard hematoxylin and eosin staining. Length and
width of rumen papillae were measured using an intra-
ocular ruler. Measurements were collected from 10
randomly selected papillae present on two different
sections (i.e., ﬁve papillae from each section). Widths
were measured at mid-shaft.
2.7. Statistical analyses
For data in which assessments were performed on
multiple days (rectal temperatures, diarrhea scores, and
fecal shedding), statistical comparisons were made using a
repeated measures analysis of variance with Tukey’s ad
hoc test for multiple comparisons (GraphPad Prism,
Version 6, La Jolla, CA). For data involving single
measurements from each calf (intestinal colonization
and rumen papillae length), statistical comparisons were
performed using a Student’s t-test (GraphPad). Signiﬁcant
differences were deﬁned at P  0.05. Statistical trends
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xamined independently (data not shown).
. Results
.1. Assessment of clinical parameters in calves
Rectal temperatures and diarrhea we monitored in the
alves on d 0, 1–7, 10, and 21 post-infection. As shown in
igs. 1 and 2, pyrexia (rectal temperature > 39.2 8C) and
iarrhea were observed less frequently (P < 0.05) in calves
d SCFP. The largest differences between calves supple-
ented with SCFP and Control calves were observed on d
–5 post-infection for rectal temperatures (38.8–39.0 8C
ersus 39.5–39.7 8C, respectively), and d 3–7 post-infec-
on for diarrhea scores (0.10–0.25 versus 0.61–0.86
rbitrary units, respectively). None of the SCFP-fed calves
xhibited pyrexia at anytime throughout the study, while
early all Control calves exhibited pyrexia on d 2–6 post-
fection. The relative incidence of diarrhea was less in
CFP-fed calves on all days except day 0 (Fig. 2b).
.2. Assessment of Salmonella shedding in the calves
Salmonella fecal shedding was monitored on d 0, 1–7, 10,
nd 21 post-infection. As shown in Fig. 3a, there was a
uantitative difference in fecal shedding between the two
less (P < 0.05) in calves fed SCFP (undetectable versus 955
CFU/g of feces). There also was a qualitative difference in
fecal shedding of Salmonella on d 3–7 post-infection (Fig. 3b).
3.3. Assessment of adherent Salmonella in the intestines of
the calves
Upon euthanasia, ileal sections were excised and
ig. 1. Time course of rectal temperatures in Salmonella-infected calves
d SCFP or the Control. Treatments include Control (no additive in milk
placer or starter grain) or SCFP (diet that contained two proprietary
accharomyces cerevisiae fermentation products (1 g/hd/d SmartCareTM
.15% inclusion rate in conventional milk replacer) and 3.5 g/hd/d
riginal XPCTM administered orally via gelatin capsule; Diamond V, Cedar
apids, Iowa). Data represent the mean  SEM for single daily measurements
n 20 calves in each group. The dashed line represents the upper limit of the
ormal rectal temperature for a calf. *P < 0.05 versus Control.
(a)
(b)
Fig. 2. (a) Time course of diarrhea scores in Salmonella-infected calves fed
SCFP or the Control. Treatments include Control (no additive in milk
replacer or starter grain) or SCFP (diet that contained two proprietary
Saccharomyces cerevisiae fermentation products (1 g/hd/d SmartCareTM
[0.15% inclusion rate in conventional milk replacer] and 3.5 g/hd/d
Original XPCTM administered orally via gelatin capsule; Diamond V, Cedar
Rapids, Iowa). Diarrhea scoring was as follows: 0, no diarrhea; 1, mild to
moderate diarrhea; 2, profuse diarrhea; or 3, profuse diarrhea with blood.
Data represent the mean  SEM for single daily measurements on 20 calves
in each group. *P < 0.05 versus the Control. (b) Time course of diarrhea
incidences in Salmonella-infected calves fed SCFP or the Control. Treatments
include Control (no additive in milk replacer or starter grain) or SCFP (diet
that contained two proprietary Saccharomyces cerevisiae fermentation
products (1 g/hd/d SmartCareTM [0.15% inclusion rate in conventional
milk replacer) and 3.5 g/hd/d Original XPCTM administered orally via gelatin
capsule; Diamond V, Cedar Rapids, Iowa). Percentages are based on the
number of calves exhibiting any type of diarrhea on a given day, with n = 20
per group on all days.ubjected to Salmonella culture and enumeration thatroups of calves on d 6 post-infection in which shedding was s
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 Fig. 4, fewer (P < 0.05) adherent Salmonella were present
 the ilea of calves fed SCFP (1620 versus 9289 CFU/g of
um). Gross examinations of the ilea revealed no
parent differences between the two groups.
. Assessment of rumen development and weight gain in the
lves
As shown in Figs. 5 and 6, rumen papillae length was
eater (P < 0.05) in calves fed SCFP (236 versus 203 mm)
hile papillae width was indistinguishable (50 versus
 mm). Table 1 shows the body weight at different stages
 experiment and Fig. 7 reveals the superior (P < 0.05)
weight gain in Salmonella-infected calves fed SCFP (23.8
versus 17.2%).
4. Discussion
Salmonella is an insidious problem for the dairy
industry. This problem represents a critical animal
health issue since cattle of all ages are affected by the
pathogen. Adult cattle will exhibit diarrhea and anorexia,
both of which compromise the performance of the
animal. In the pre-weaned calf, Salmonella can cause
diarrhea and malaise that will also hamper performance
and expose caretakers to the pathogen. Furthermore,
salmonellosis in the pre-weaned calf can lead to
(a)
(b)
. 3. (a) Time course of Salmonella fecal shedding in Salmonella-infected calves fed SCFP or the Control. Treatments include Control (no additive in milk
lacer or starter grain) or SCFP (diet that contained two proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d SmartCareTM [0.15%
lusion rate in conventional milk replacer) and 3.5 g/hd/d Original XPCTM administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa). Data
resent the mean  SEM for single daily measurements on 20 calves in each group. *P < 0.05 versus SCFP. (b) Time course of fecal shedding incidences in
monella-infected calves fed SCFP or the Control. Treatments include Control (no additive in milk replacer or starter grain) or SCFP (diet that contained two
prietary Saccharomyces cerevisiae fermentation products (1 g/hd/d SmartCareTM [0.15% inclusion rate in conventional milk replacer) and 3.5 g/hd/d Original
CTM administered orally via gelatin capsule; Diamond V, Cedar Rapids, Iowa). Percentages are based on the number of calves shedding any detectable amount of
monella on a given day, with n = 20 per group on all days.
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ecome an asymptomatic source of Salmonella for the
erd, while some animals may perish because of the
fection.
Identifying Salmonella mitigation strategies is of critical
igniﬁcance yet the progress is very slow. In this study, the
anti-Salmonella effects of SCFP were examined and three
critical indicators of salmonellosis (pyrexia, diarrhea, and
intestinal colonization) were signiﬁcantly reduced by
SCFP. The absence of pyrexia and the diminished diarrhea
in the calves fed SCFP are consistent with the reduced
intestinal colonization by Salmonella. Both pyrexia and
diarrhea are dependent upon pathogen burden and it
appears that Salmonella may be less efﬁcient at attaching to
the intestinal tract in the presence of SCFP. This diminished
intestinal colonization was manifested by a cessation of
Salmonella shedding in calves fed SCFP at 4 d prior to the
last day of fecal shedding in calves fed the Control. In
Control-fed calves, a higher number of adherent Salmonella
were present in the intestinal tract thus extending the
overall shedding period, which ultimately increased
the risk of disease transmission. While we did not measure
intracellular bacteria in the gut epithelium, we do not
envision that differences in intracellular bacteria would
account for a ﬁve-fold difference in the recovery of the
Salmonella in the two groups.
Our results are consistent with a previous study
(Magalha˜es et al., 2008) in which feeding SCFP led to an
improvement of gastrointestinal health in pre-weaned
dairy calves naturally exposed to Salmonella. Although the
mechanism of action is yet to be clariﬁed, the effect of SCFP
on intestinal colonization (Ibukic et al., 2012) and growth
ig. 4. Salmonella ileal colonization in Salmonella-infected calves fed SCFP
lled column) or the Control (open column). Treatments include Control
o additive in milk replacer or starter grain) or SCFP (diet that contained
o proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/
 SmartCareTM [0.15% inclusion rate in conventional milk replacer) and
.5 g/hd/d Original XPCTM administered orally via gelatin capsule;
iamond V, Cedar Rapids, Iowa). Data represent the mean  SEM for
ngle measurements on 20 calves in each group. *P < 0.05 versus the
ontrol.
ig. 5. Rumen papillae dimensions in Salmonella-infected calves fed SCFP
r the Control. Treatments include Control (no additive in milk replacer or
arter grain) or SCFP (diet that contained two proprietary Saccharomyces
revisiae fermentation products (1 g/hd/d SmartCareTM [0.15% inclusion
te in conventional milk replacer) and 3.5 g/hd/d Original XPCTM
dministered orally via gelatin capsule; Diamond V, Cedar Rapids,
wa). Data represent the mean  SEM for measurements on 20 calves in
ach group. Rumen papillae were measured ten times for each animal.
idths were measured at the mid-shaft of the papillae. *P < 0.05 versus the
ontrol.
Fig. 6. Representative rumen papillae photomicrographs (40) of
hematoxylin-eosin stained sections from Salmonella-infected calves
SCFP (top) or the Control (bottom). Treatments include Control (no
additive in milk replacer or starter grain) or SCFP (diet that contained two
proprietary Saccharomyces cerevisiae fermentation products (1 g/hd/d
SmartCareTM [0.15% inclusion rate in conventional milk replacer) and
3.5 g/hd/d Original XPCTM administered orally via gelatin capsule;
Diamond V, Cedar Rapids, Iowa). Papillae are longer in calves fed SCFP,
whereas papillae widths are indistinct. A 100 mm scale bar is present on
the bottom right of each photo.
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s also been reported in poultry.
Other signiﬁcant ﬁndings in this study are the improved
eight gain and rumen papillae maturation in calves
d SCFP, which is consistent with a non-infectious
dy whereby supplemental SCFP improved pre-weaning
lf growth, feed intake, and corresponding rumen
velopment parameters (Lesmeister et al., 2004). Al-
ough it is unclear how these parameters were improved
 feeding the S. cerevisiae fermentation products, these
dings suggest an economic beneﬁt for inclusion in milk
placer and starter grain as demonstrated previously
agalha˜es et al., 2008). It is likely that these beneﬁts
tend to calves in herds even in which Salmonella is not
demic. Furthermore, it is possible that these beneﬁts
extend to protection from related enteric pathogens such
as Escherichia coli since previously reported studies
suggested SCFP could inhibit the growth of E. coli (Jensen
et al., 2008b). Future studies will assess this possibility.
5. Conclusions
In summary, Salmonella-infected dairy calves were
signiﬁcantly less likely to exhibit clinical signs associated
with salmonellosis when fed SCFP. Speciﬁcally, these
calves were less likely to exhibit pyrexia and diarrhea,
possibly as a direct result of diminished intestinal
colonization by Salmonella. Ultimately, these protective
effects augmented growth and improved rumen develop-
ment in the calves infected with a serious enteric
pathogen.
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